youtube_live
Q3 2026 earnings • in 1 day
See detailschevron_right
UTHR:NASDAQ
United Therapeutics Corp
$596.13
arrow_downward
-0.43%(-2.59) 1D
$596.13
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$596.54
High
$600.90
Low
$592.46
Mkt. cap
25.57B
Avg. vol.
809.79K
Volume
0.00
P/E ratio
21.32
52-wk high
$609.99
52-wk low
$430.02
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
Open
$596.54
High
$600.90
Low
$592.46
Mkt. cap
25.57B
Avg. vol.
809.79K
Volume
0.00
P/E ratio
21.32
52-wk high
$609.99
52-wk low
$430.02
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
TradingView
·
2 hours ago
United Therapeutics (UTHR) to report earnings tomorrow: here is what to expect
www.marketscreener.com
·
8 hours ago
United Therapeutics Insider Sold Shares Worth $5,700,856, According to a Recent SEC Filing
Benzinga
·
14 hours ago
SpaceX Launch Customer Varda Says a Single Flight Could Help Make Medicine for Millions
Investing.com
·
22 hours ago
United Therapeutics evp Paul Mahon sells $4.1M in UTHR shares
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com